
Iovance Biotherapeutics, Inc.
USD4.21
-0.04 (-0.94%)
CEO
Frederick G. Vogt
IPO Date
2010-10-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.33
Prev. Close
$4.25
Day Low
$4.17
Day High
$4.46
52W Low
$1.67
52W High
$5.63
Market Cap
$1.51B
Volume
10.61M
| 3 Mar 2026 |
| Citizens |
| Market Perform |
| Market Outperform |
| upgrade |
| 25 Feb 2026 | Barclays | Overweight | Overweight | maintain |
| 25 Feb 2026 | Citizens | Market Perform | Market Outperform | upgrade |
| 17 Dec 2025 | Barclays | Overweight | Overweight | maintain |
| 24 Nov 2025 | Barclays | Overweight | Overweight | maintain |
| 6 Nov 2025 | Chardan Capital | Buy | Buy | maintain |
| 29 Oct 2025 | HC Wainwright & Co. | Buy | Buy | maintain |